PepGen (PEPG) Non-Current Assets (2021 - 2026)
PepGen (PEPG) reported Non-Current Assets of $22.0 million for Q1 2026, down 16.4% on a YoY basis from $26.3 million in Q1 2025, and down 4.01% sequentially from $22.9 million in Q4 2025.
PepGen (PEPG) Non-Current Assets (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Non-Current Assets data on file, last reported at $22.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 16.4% year-over-year to $22.0 million; the trailing twelve-month figure through Mar 2026 stood at $93.6 million (down 14.98% YoY), and the FY2025 full-year result was $22.9 million, down 15.4% from the prior year.
- Non-Current Assets eased to $22.0 million in Q1 2026, from $22.9 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $32.6 million in Q1 2023 to a low of $4.2 million in Q3 2022.
- A 5-year average of $23.8 million and a median of $27.1 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 757.92% in 2022 and fell 16.4% in 2026, its largest moves.
- Tracing PEPG's Non-Current Assets over 5 years: stood at $31.4 million in 2022, then dropped by 3.13% to $30.4 million in 2023, then fell by 10.71% to $27.1 million in 2024, then decreased by 15.4% to $22.9 million in 2025, then retreated by 4.01% to $22.0 million in 2026.
- Business Quant data shows PEPG's Non-Current Assets at $22.0 million in Q1 2026, $22.9 million in Q4 2025, and $23.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 285.82 Mn |
| 10 | PepGen | 133.69 Mn | 133.69 Mn | - | 22.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.02 Mn |
| Dec 31, 2025 | 22.94 Mn |
| Sep 30, 2025 | 23.85 Mn |
| Jun 30, 2025 | 24.76 Mn |
| Mar 31, 2025 | 26.35 Mn |
| Dec 31, 2024 | 27.12 Mn |
| Sep 30, 2024 | 27.87 Mn |
| Jun 30, 2024 | 28.73 Mn |
| Mar 31, 2024 | 29.38 Mn |
| Dec 31, 2023 | 30.37 Mn |
| Sep 30, 2023 | 31.18 Mn |
| Jun 30, 2023 | 31.71 Mn |
| Mar 31, 2023 | 32.57 Mn |
| Dec 31, 2022 | 31.36 Mn |
| Sep 30, 2022 | 4.21 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 6.21 Mn |
| Dec 31, 2021 | 3.66 Mn |